Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific

Annals of the Rheumatic Diseases

Volumn 56, Issue 9, 1997, Pages 542-549

  Freemont, A J ^a   Hampson, V ^a   Tilman, R ^b   Goupille, P ^c   Taiwo, Y ^d   Hoyland, J A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITÉ DE TOURS   (France)

^d PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE B; STROMELYSIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHONDROLYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNEE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL;

EID: 0030763570     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.9.542     Document Type: Article

References (57)

1. Cawston TE, Billington C. Metalloproteinases in the rheumatic diseases. J Pathol 1996;180:115-7.
2. Pelletier J P, Martel-Pelletier J, Malemud C J. Proteoglycans from experimental osteoarthritic cartilage: degradation by neutral metalloproteinases. J Rheumatol 1987;14:113-5.
3. McCachren S S. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991;34:1085-93.
4. Case J P, Lafyatis R, Remmers EF, Kumkunian GK, Wilder RL. Transin/stromelysin expression in rheumatoid synovium: a transformation-associated metalloprotemase secreted by phenotypically invasive synoviocytes. Am J Pathol 1989;135:1055-64.
5. Cooper C. Osteoarthritis: epidemiology. In: Klippel J H, Dieppe P, eds. Rheumatology. London: A Mosby, 1994: section 7, subsection 3.
6. Martel-Pelletier J, Pelletier J P. Neutral proteases in human osteoarthritic synovium: quantification and characterization. J Rheumatol 1987;14:38-40.
7. Woessner J F Jr, Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol 1991;18:99-101.
8. Dean D D, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
9. Pelletier J P, Mineau F, Faure MP, Martel-Pelletier J. Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 1990;33:1466-76.
10. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-15.
11. Wolfe G C, MacNaul K L, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Arthritis Rheum 1993;36:1540-7.
12. Sapolsky A, Malemud C, Sheff M. The proteoglycanase from human cartilage and cultured rabbit chondrocytes and its relation to osteoarthritis. J Rheumatol 1987;14:33-5.
13. Dean D D, Azzo W, Martel-Pelletier J, Pelletier JP, Woessner JF jr. Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage. J Rheumatol 1987;14:43-4.
14. Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP In-vitro effects of interleukin 1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human cartilage. J Rheumatol 1991;27 (suppl):80-4.
15. Shingu M, Miyauchi S, Nagai Y, Yasutake C, Horie K. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br J Rheumatol 1995;34:101-6.
16. Martel-Pelletier J, Pelletier J-P. Wanted - the collagenase responsible for the destruction of the collagen network in human cartilage! Br J Rheumatol 1996;35:818-20.
17. Zafarullah M, Pelletier JP, Cloutier JM, Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metallo-proteinase mRNA in human osteoarthritic synovia. J Rheumatol 1993;20:693-7.
18. Lefebvre V, Peeters-Joris C, Vaes G. Production of gelatin-degrading matrix metalloproteinase ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumour necrosis factor alpha. Biochim Biophys Acta 1991;1094:8-18.
19. Mehraban F, Kuo SY, Riera H, Chang C, Moskowitz RW. Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum 1994;37:1189-97.
20. Andrew JG, Hoyland JA, Freemont AJ, Marsh DR. Platelet derived growth factor expression in normally healing human fractures. Bone 1995;16:455-60.
21. Andrew JG, Hoyland JA, Andrew SM, Marsh D, Freemont AJ. Demonstration of TGF-B1 in normally healing fracture callus by in-situ hybridisation. Calcif Tissue Int 1993;52:74-8.
22. Pelletier JP, Roughley PJ, DiBattista JA, McCollum R, Martel-Pelletier J. Are cytokines involved in osteoarthritic pathophysiology? Semin Arthritis Rheum. 1991;20 (suppl 2): 12-25.
23. Crossley M J, Connon A M, Hunneyball T M. The possible role of synovial factors in cartilage destruction. Agents Actions 1986;18 (suppl):39-42.
24. Bunning R A, Richardson H J, Crawford A, Skjodt H, Hughes D, Evans DB, et al. The effect of interleukin-1 on connective tissue metabolism and its relevance to arthritis. Agents Actions 1986;18 (suppl):131-52.
25. Mort JS, Dodge GR, Roughley PJ, Liu J, Finch SJ, DiPasquale G, et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 1993;13:95-102.
26. Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga, Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 1993;94:145-9.
27. Aydeloote MB, Schumacher BL, Kuettner KE. Heterogeneity of articular chondrocytes. In: Kuettner KE, Schleyerbach R, Peyron JG, eds. Articular cartilage and ostcoarthritis. New York: Raven Press, 1992:237-49.
28. Manicort DH, Pita JC, Thonar EJ, Howell DS. Proteoglycans nondissociatively extracted from different zones of canine normal articular cartilage: variations in the sedimentation profile of aggregates with degree of physiological stress. Connect Tissue Res 1991;26:231-40.
29. Manicourt DH, Pita JC, McDevitt CA, Howell DS. Superficial and deeper layers of dog normal articular cartilage. Role of hyaluronate and link protein in determining the sedimentation coefficients distribution of the nondissociatively extracted proteoglycans. J Biol Chem 1988;263:13121-9.
30. Setton LA, Mow VC, Muller FJ, Pita JC, Howell DS. Altered structure-function relationships for articular cartilage in human osteoarthritis and an experimental canine model. Agents Actions 1993;39 (suppl):27-48.
31. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in ageing and osteoarthritis starts at the articular surface, originates around chondrocytes and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
32. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
33. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, et al. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 1996;74:232-40.
34. Pelletier JP, Martel-Pelletier J, Cloutier JM, Woessner JF Jr. Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage and the effect of intraarticular steroid injections. Arthritis Rheum 1987;30:541-8.
35. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localisation of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium, Lab Invest 1992;66:680-0.
36. Ito A, Nose T, Takahashi S, Mori Y. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes. FEBS Lett 1995;360:75-9.
37. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI. Expression of 92kd type IV collagenase gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human cartilage by interleukin-1. J Clin Invest 1993;92:179-85.
38. Werb Z, Alexander C M. Proteinases and matrix degradation, In: Kelley W N, Harris E D Jr, et al, eds. Textbook of rheumatology. Philadelphia: W B Saunders, 1993:48-68.
39. Yu L P Jr, Smith G N Jr, Brandt KD, Capello W. Type XI collagen-degrading activity in human osteoarthritic cartilage. Arthritis Rheum 1990;33:1626-33.
40. Mort JS, Dodge GR, Roughley PJ, Liu J, Finch SJ, Dipasquale G, et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 1993;13:95-102.
41. Martell-Pelletier J, Pelletier JP. Neutral metalloproteinases and age related changes in human articular cartilage Ann Rheum Dis 1987;46:363-9.
42. Hoyland J, Freemont A Investigation of a quantitative post-hybridization signal amplification system for mRNA-oligodeoxyribobucleotide in-situ hybridization. J Pathol 1991;164:51-8.
43. Marles PJ, Hoyland JA, Parkinson R, Freemont AJ. Demonstration of variation in chondrocyte activity in different zones of articular cartilage - an assessment of the value of in-situ hybridisation. Int J Exp Pathol 1991;72:171-82.
44. Hoyland JA, Freemont AJ, Sharpe P. Interleukin 6 (IL-6), IL-6 Receptor and IL-6 nuclear factor gene expression in Pagets disease. J Bone Min Res 1994;9:75-80.
45. Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer FB, Freemont AJ. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 1997;20:87-92.
46. Walsh L, Freemont AJ, Hoyland JA. The effect of tissue decalcification on mRNA retention with bone for in-situ hybridisation studies. Int J Exp Pathol 1993;74:237-41.
47. Chubiskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, et al. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271:11023-6.
48. Sakiyama H, Inaba N, Toyoguchi T, Okada Y, Matsumoto M, Moriya H, et al. Immunolocalisation of complement C1s and matrix metalloproteinase 9 (92kDa gelatinase type IV collagenase) in the primary ossification center of the human femur. Cell Tissue Res 1994;277:239-45.
49. Hasty KA, Reife RA, Kang AH, Stuart JM. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990;33:388-97.
50. Pelletier JP, DiBattista JA, Raynauld JP, Wilhelm S, Martel-Pelletier J. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis. Lab Invest 1995;72:578-86.
51. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J. Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 1993;142:95-105.
52. Nguyen Q, Mort J S, Roughley P J. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localisation in human articular cartilage. J Clin Invest 1992;89:1189-97.
53. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg 1971;53A:523-37.
54. Blair HC, Dean DD, Howell DS, Teitelbaum SL, Jeffrey JJ. Hypertrophic chondrocytes produce immunoreactive collagenase in vivo. Connect Tissue Res 1989;23:65-73.
55. Hauselmann HJ, Fletchenmacher J, Michal L, Thonar FJ, Shinmei M, Kuettner KE. The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum 1996;39:478-88.
56. Cole AA, Kuettner KE. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop Scand 1995;66:98-102.
57. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesised by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996;97:2011-9.